Your browser doesn't support javascript.
loading
Epstein-Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases.
Camacho Castañeda, Francisca Inmaculada; Dotor, Ana; Manso, Rebeca; Martín, Paloma; Prieto Pareja, Elena; Palomo Esteban, Teresa; García Vela, José Antonio; Santonja, Carlos; Piris, Miguel A; Rodríguez Pinilla, Socorro María.
Afiliação
  • Camacho Castañeda FI; Pathology Department, Hospital Universitario de Getafe, Madrid, Spain.
  • Dotor A; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Manso R; Pathology Department, Madrid, Spain.
  • Martín P; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Prieto Pareja E; Haematology Department, Fundación Jiménez Díaz, Madrid, Spain.
  • Palomo Esteban T; Haematology Department, Fundación Jiménez Díaz, Madrid, Spain.
  • García Vela JA; Haematology Department, Hospital Universitario de Getafe, Madrid, Spain.
  • Santonja C; Pathology Department, Madrid, Spain.
  • Piris MA; Pathology Department, Madrid, Spain.
  • Rodríguez Pinilla SM; Pathology Department, Madrid, Spain.
Histopathology ; 77(1): 112-122, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32145092
ABSTRACT

AIMS:

To present four examples of clonally related Epstein-Barr virus (EBV)-associated large-cell transformation of marginal zone lymphoma (MZL) (of nodal, extranodal and splenic types), occurring 120, 11 and 5 months after the initial diagnosis in three instances, and concurrently in one case; and to discuss several interesting features of EBV infection. METHODS AND

RESULTS:

Somatic mutations were detected by use of a customised panel for next-generation sequencing and polymerase chain reaction studies of IgH in both low-grade and high-grade components of each case. In case 1, the initial biopsy of nodal MZL showed scattered EBV-positive cells, which might constitute an indication of EBV-induced progression. Case 2 showed heterogeneous EBV expression, a phenomenon attributable to loss of the EBV episomes during cell division, or to a secondary superinfection or reactivation of the virus. In case 3, p53 overexpression related to gene mutation and EBV-encoded small RNAs were identified in the same neoplastic component. In case 4, the mucosa-associated lymphoid tissue-type MZL and the high-grade component were identified concurrently in a patient previously treated with methotrexate for an autoimmune disorder.

CONCLUSION:

These data suggest that the presence of EBV should be added to the list of potential markers to be analysed for MZL prognosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Linfoma Difuso de Grandes Células B / Linfoma de Zona Marginal Tipo Células B / Infecções por Vírus Epstein-Barr Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Linfoma Difuso de Grandes Células B / Linfoma de Zona Marginal Tipo Células B / Infecções por Vírus Epstein-Barr Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article